MissionIR Articles
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports Promising Prophylactic Results from Preclinical Proof-of-Concept NanoAb COVID-19 Study
Focused on the development, manufacture, and commercialization of innovative NanoAb immunotherapeutic products, BiondVax Pharmaceuticals (NASDAQ: BVXV) recently announced additional results in the company’s preclinical proof-of-concept study of its inhaled nanosized VHH-antibody (NanoAb) COVID-19 drug (https://ibn.fm/Kz8W4).…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) Establishing Itself as a Name Brand in North America’s RNG Industry
EverGen (TSX.V: EVGN) (OTCQX: EVGIF), a leading Canadian renewable energy company and Canada’s renewable natural gas (“RNG”) infrastructure platform, is aggressively expanding nationwide. “Amassing an impressive portfolio of projects and partners, EverGen is establishing itself…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Eyes Potential Extension of Overall Deposit at Iska Iska, Adjoining Properties
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company, is focused on its key Bolivian property Iska Iska. “Iska Iska is located in the prolific Potosi region of Southern Bolivia,…
-
MissionIRNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Reducing Overall Barrier of Entry into Renewable Energy Space
Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled provider of distributed energy solutions across North America, is addressing legitimate concerns that building owners have regarding short and long-term returns of potential retrofits through its advanced energy…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Anticipating ‘Best Year Ever’ in 2023
Lexaria Bioscience (NASDAQ: LEXX) started calendar 2022 with optimism, which according to CEO Chris Bunka’s recently published annual letter to shareholders (https://ibn.fm/zu8hP), turned out to well founded. Now, as the company begins calendar 2023, “that…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Momentum with Five New Contracts
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and emergency systems, today announced that it has secured five customer expansion orders adding to its ongoing sales growth. The company’s K1 Emergency Communication Systems…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), McEwen Copper Inc. Announce Robust Assay Results at Los Azules, Engagement of IBN for Corporate Communications Expertise
McEwen Copper Inc., 68%-owned by McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), today announced rich copper values over attractive widths resulting from infill drilling at its Los Azules project. A large porphyry copper-gold-silver deposit, Los…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Virtual R&D Day
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has scheduled a virtual R&D Day for Feb. 28, 2023; the event is scheduled from 10 to 11:30 a.m. ET. The…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Special Shareholder Meeting, Announces Key New Hires
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is releasing results from its reconvened Special Meeting of Stockholders. The meeting, which was held on Jan. 25, 2023, included several proxy proposals on the…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Year-End Webcast Review
Flora Growth (NASDAQ: FLGC), a leading outdoor grower, manufacturer and distributor of cannabis products and brands worldwide, has scheduled a webcast to provide an overview of the company’s operational milestones achieved in 2022. The year-end…
-
Silo Pharma Inc. (NASDAQ: SILO) Provides Update on UCSF Psylocibin Clinical Trial
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company that fuses traditional medicine with psychedelics, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the…
-
MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) CEO Discusses Top-down Culture of Cybersecurity in ‘Shrimp Tank’ Interview
CISO Global (NASDAQ: CISO), an industry leader in managed cybersecurity and compliance services, was featured on a recent episode of “The Shrimp Tank.” The company’s CEO David Jemmett joined podcast host Ted Jenkin to discuss…
-
MissionIRNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) $4.1M Placements Supported by Aegis Capital Corp. as Exclusive Placement Agent
Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, recently announced the closing of both a registered direct and a private placement; the placements totaled approximately $4.1 million. Aegis Capital Corp.…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability to Meet Underserved Medical Needs
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is using its patented DehydraTECH(TM) technology to improve bioavailability and how active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery,…
-
Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Set to Potentially Benefit as Renowned Gold Bug, Claude Bejet, Says Now is the Time to Invest in Precious Metals
“We’ve been through hell.” That was Claude Bejet’s succinct summary of the precious metals market and gold over the past two years. A Covid-linked downturn in 2020 was subsequently followed by an inflation-driven bear market…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses ‘Lifeblood’ of Phase 2 Berubicin Trial
CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biopharmaceutical company focused on developing novel treatments for primary and metastatic cancers in the brain and central nervous system, is enrolling patients in a phase 2 trial to evaluate…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Working Toward Global Leadership in CBD Space
Flora (NASDAQ: FLGC) has transitioned from the development stage to a full-scale international distributor with operations in over 12 countries worldwide, achieved under Luis Merchan’s tenure as CEO. “Merchan has also spearheaded several mergers and…
-
MissionIRNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Senior Medical Tech Veteran as New President
HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has appointed Robert Eno to the newly created position of president.…
Search Articles
Latest Articles
- Vision Marine Technologies Inc. (NASDAQ: VMAR) Expands Distribution Network, Signs Exclusive Nimbus Boats Agreement for Florida’s West Coast
- D-Wave Quantum Inc. (NYSE: QBTS) Targets Processor Development Scalability with Advanced Cryogenic Packaging Initiative
- Lantern Pharma Inc. (NASDAQ: LTRN) Reports Q2 Results with Clinical Trial, AI Platform Advancements
- MissionIRNewsBreaks – RapidSX(TM) Powers Ucore Rare Metals Inc.’s (TSX.V: UCU) (OTCQX: UURAF) Role in Rebuilding Mineral Independence
- MissionIRNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Reaffirms E-Motion(TM) as World’s Fastest Electric Boat Technology